Health Care/Hospital
Alphamab Oncology to Present the Preclinical Results of PD-L1/OX40 Bispecific Antibody KN052 at AACR 2023
SUZHOU, China, March 15, 2023 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the preclinical result of KN052 (PD-L1/OX40 bispecific antibody) is accepted as Late-Breaking Research in 114th Annual Meeting of the American Association for Cancer Research (AACR 2023). The res...
2023-03-15 10:06
2324
Illumina launches its first product enabling long- and short-read sequencing on one instrument
Early customer data reinforces accuracy and flexibility of novel long-read technology, unlocking access to challenging, low DNA input samples SAN DIEGO, March 15, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced th...
2023-03-15 08:00
2100
Ascentage Pharma to Present Latest Results from Three Preclinical Studies at 2023 American Association for Cancer Research Annual Meeting
SUZHOU, China and ROCKVILLE, Md., March 14, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the latest results from three preclinical s...
2023-03-15 07:59
2744
Medical Park Hospitals Group MD, Assoc. Prof. Neurosurgeon, Sait Öztürk has successfully accomplished Brain Pacemaker surgery while awake and watching cartoons to DYSTONIA PATIENT ZEYNEP
ISTANBUL, March 15, 2023 /PRNewswire/ -- Zeynep Liva Elmacı, a dystonia patient who has been having uncontrollable involuntary contractions in her legs and arms for the last 5 years, underwent brain pacemaker surgery while awake by watching cartoons. The patient's surgery was performedMedical Par...
2023-03-15 06:00
1876
YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION
* Business Combination to deliver approximately $36 million of gross proceeds * YS Biopharma expects to close the Business Combination on March 16, 2023 * YS Biopharma Ordinary Shares and YS Biopharma Warrants expected to begin trading on the Nasdaq onMarch 17, 2023 under the symbols "YS" and...
2023-03-15 04:01
3675
Medical Tourism Moonshot: Breaking the Barriers to Quality Healthcare
PALM BEACH GARDENS, Fla., March 15, 2023 /PRNewswire/ -- The Medical Tourism Association in collaboration with Global Healthcare Resources and the International Healthcare Research Center have launched the firstMedical Tourism Moonshot to break down the major barriers preventing access and growth...
2023-03-15 02:55
2262
Mabwell Launched First in human Clinical Trial of Its Iron Homeostasis Regulating Macromolecular Drug 9MW3011
SHANGHAI, March 14, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, launched first in human clinical trial of its iron homeostasis regulating macromolecular drug 9MW3011. The study (CTR20230046) is a phase 1, single cente...
2023-03-14 23:42
2055
Picarro's New 1-ppb Class Chemical Metrology Solution for Lithography Process Tool Monitoring Enables Semiconductor Fabs to Improve Process Control
SLiM 100 delivers real-time detection and quantification of VOCs to the 1 ppb level SANTA CLARA, Calif., March 14, 2023 /PRNewswire/ -- Picarro Inc., a leading provider of chemical metrology systems for advanced semiconductor fabs, today announced theSLiM 100 Lithography Process Tool Monitoring ...
2023-03-14 22:10
2517
USAID-FUNDED PROJECT RECOGNIZES EIGHT ORGANIZATIONS FOR LEADERSHIP IN ADOPTING ANTIMICROBIAL USE STEWARDSHIP PRINCIPLES
Developed by the International Poultry Council, the principles aim to optimize animal health to reduce reliance on antimicrobials TUCKER, Ga., March 14, 2023 /PRNewswire/ -- The International Poultry Council (IPC) is pleased to announce eight private-sector organizations have recognized the impo...
2023-03-14 21:00
2245
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
New Business Strategy Focused on Precision Oncology LONDON and HONG KONG, March 14, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial results for the fourth quarter and full yea...
2023-03-14 20:56
7691
Servier's Pivotal Phase 3 INDIGO Trial Investigating vorasidenib in IDH-Mutant Low-Grade Glioma Meets Primary Endpoint of Progression-Free Survival (PFS) and Key Secondary Endpoint of Time to Next Intervention (TTNI)
* Clinically meaningful achievement of primary and secondary endpoints is first major advance in treatment of low-grade glioma in more than 20 years * Endpoints met in a prespecified interim analysis * vorasidenib granted fast track designation by U.S. Food & Drug Administration (FDA) PARI...
2023-03-14 20:24
2047
Ajinomoto Bio-Pharma Services Awarded Three 'CDMO Leadership Awards'
SAN DIEGO and TOKYO and WETTEREN, Belgium, March 14, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received three CDMO Leadership Awards in the categories Capabilities, Compatibility,...
2023-03-14 20:05
1602
Simcere Zaiming Announces Clinical Collaboration to Evaluate SIM0235, a TNFR2 Monoclonal Antibody, in Combination with KEYTRUDA® (pembrolizumab) in a Phase 1 Trial in Advanced Solid Tumors and Cutaneous T-cell Lymphoma
NANJING, China, March 14, 2023 /PRNewswire/ -- Simcere Pharmaceutical Group Limited (2096.HK) (Simcere), an innovative global biopharmaceutical company, announced today that Simcere Zaiming, an innovative oncology pharmaceutical company of Simcere has entered into a clinical collaboration agreeme...
2023-03-14 20:00
2194
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022
SUZHOU, China, March 14, 2023 /PRNewswire/ -- magAssist Inc.
2023-03-14 18:30
1585
So-Young to Report Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023
BEIJING, March 14, 2023 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community inChina for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its fina...
2023-03-14 17:30
1903
Patient Enrollment Completed for Phase III Clinical Trial of Akeso's Cadonilimab in Treatment of Gastric Cancer
HONG KONG, March 14, 2023 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced that patient enrollment has been completed for its pivotal Phase III clinical trial for cadonilimab (PD-1/CTLA-4 bi-specific antibody, AK104), the world's first approved and marketed dual-immune checkpoint bi-specific antib...
2023-03-14 17:01
1257
OSANO Debuts Latest Products at COSMOPROF 2023
BOLOGNA, Italy, March 14, 2023 /PRNewswire/ -- COSMOPROF WORLDWIDE BOLOGNA, one of the most influential global events dedicated to all facets of the beauty industry,is taking place from the 17th to 20th, March, 2023. OSANO launched a series of top-notch products, including Beauty Equipment, Body ...
2023-03-14 16:48
1384
DeepCare debuts at IDS Cologne 2023
COLOGNE, Germany, March 14, 2023 /PRNewswire/ -- DeepCare, a leading AI solution provider for dental care, debuts its latest innovative products at the International Dental Show (IDS) inCologne, Germany, from March 14th to 18th, 2023. IDS is the world's largest and most influential dental exhibit...
2023-03-14 16:00
1488
Antengene Announces IND Approval for the Phase I CLINCH Trial of ATG-022 (Claudin 18.2 ADC) for the Treatment of Advanced or Metastatic Solid Tumors in China
- Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Associated Antigen (TAA) Claudin 18.2. - The Phase I CLINCH trial is designed to evaluate the safety, pharmacology, and preliminary efficacy of ATG-022 monotherapy in pat...
2023-03-14 12:29
2301
BEYOND Expo Back in Macao for 2023 to See "Technology Redefined" in one of Asia's Biggest Tech Events
MACAO, March 14, 2023 /PRNewswire/ -- Now on its third edition, BEYOND International Technology Innovation Expo (BEYOND Expo) returns to its real-world conference format inMacao from May 10 to 12, 2023. The live-streamed and in-person conference format will provide exhibitors and attendees with m...
2023-03-14 09:00
2887
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 282 media titles]
2024-04-18 21:26
Animated Life in Yunnan
[Picked up by 278 media titles]
2024-04-18 14:00
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 277 media titles]
2024-04-19 13:25
Most Read
Sephora appoints Xia Ding as Managing Director of Sephora Greater China
2024-04-15 17:33
3819
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
3618
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
2024-04-15 08:00
3085
Goldpac Exhibits at InnoEx 2024
2024-04-13 10:00
3023